Mahajan, Anjlee Brunson, Ann Keegan, Theresa H M Rosenberg, Aaron Wun, Ted
Published in
Leukemia & lymphoma
Venous thromboembolism (VTE) and major bleeding in primary central nervous system lymphoma (PCNSL) patients are not well described. We identified 992 PCNSL patients using the California Cancer Registry (2005-2014). The cumulative incidence of VTE and major bleeding was determined using California hospitalization data. The 12-month cumulative incide...
Ishii, Mitsuru
Kyoto University (京都大学) / 0048 / 新制・論文博士 / 博士(医学) / 乙第13370号 / 論医博第2207号 / 新制||医||1047(附属図書館) / (主査)教授 大鶴 繁, 教授 中山 健夫, 教授 髙橋 良輔 / 学位規則第4条第2項該当
Chan, Yi-Hsin Wu, Lung-Sheng See, Lai-Chu Liu, Jia-Rou Chang, Shang-Hung Chao, Tze-Fan Yeh, Yung-Hsin Kuo, Chi-Tai Lee, Hsin-Fu Lip, Gregory Y H
...
Published in
The Journal of clinical endocrinology and metabolism
Patients with hyperthyroidism were excluded from the randomized clinical trials of direct oral anticoagulants (DOACs) for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF). We performed a nationwide retrospective cohort study using data from the Taiwan National Health Insurance Research Database. We enrolled 3213 and 1181 NV...
Krittayaphong, Rungroj Chichareon, Ply Komoltri, Chulalak Kornbongkotmas, Sakaorat Yindeengam, Ahthit Lip, Gregory Y. H.
Published in
Journal of Clinical Medicine
We aimed to determine if low body weight (LBW) status (
Frere, Corinne Crichi, Benjamin Bournet, Barbara Canivet, Cindy Abdallah, Nassim Ait Buscail, Louis Farge, Dominique
Published in
Cancers
Patients with pancreatic cancer (PC) carry the highest risk of venous thromboembolism (VTE) amongst all cancer patients. Appropriate use of primary thromboprophylaxis might significantly and safely reduce its burden. We performed a systematic review of published studies and meeting abstracts using MEDLINE and EMBASE through July 2020 to evaluate th...
Li, Guowei Zeng, Jie Zhang, Junguo Thabane, Lehana
Published in
Frontiers in Medicine
Background: There is no direct comparison from clinical trials amongst the direct oral anticoagulants (DOACs) in patients with acute venous thromboembolism (VTE), leaving an evidence gap in decision-making regarding the choice of a DOAC. Methods: We performed a systematic review for an indirect comparison from randomized controlled trials (RCTs) fo...
Bhardwaj, Priya Petersen, Louise Breum Binko, Tomas Sorm Petersen, Jan Roland Fornitz, Gitte Gleerup
Published in
The Journal of International Medical Research
Introduction Patients treated with direct oral anticoagulants (DOACs) are at increased bleeding risk. It is therefore of increasing interest to identify predictors of bleeding episodes to increase safety during treatment with DOACs. Methods This retrospective cohort study systematically reviewed medical records of 235 patients treated with either a...
Christersson, Christina James, Stefan K Lindhagen, Lars Ahlsson, Anders Friberg, Örjan Jeppsson, Anders Ståhle, Elisabeth
Published in
Heart (British Cardiac Society)
To compare effectiveness of warfarin and antiplatelet exposure regarding both thrombotic and bleeding events, following surgical aortic valve replacement with a biological prosthesis(bioSAVR). The study included all patients in Sweden undergoing a bioSAVR during 2008-2014 who were alive at discharge from the index hospital stay. Exposure was analys...
Pompilio, Giuseppe Integlia, Davide Raffetto, Joseph Palareti, Gualtiero
Published in
TH Open: Companion Journal to Thrombosis and Haemostasis
Objective This network meta-analysis (NMA) assesses the clinical comparative efficacy and safety of sulodexide versus direct-acting oral anticoagulants (DOACs), vitamin K antagonist (VKA), and aspirin in patients with an unprovoked venous thromboembolism (VTE). Methods We conducted a literature search in MEDLINE, Embase, and Cochrane Library using ...
Deitelzweig, Steven Baker, Christine L. Dhamane, Amol D. Mardekian, Jack Dina, Oluwaseyi Rosenblatt, Lisa Russ, Cristina Poretta, Tayla Lingohr-Smith, Melissa Lin, Jay
...
Published in
Journal of Drug Assessment
Objectives To compare the risks of 1-month all-cause, major bleeding (MB)-related and stroke-related readmissions and the associated hospital resource use and costs among patients previously hospitalized for nonvalvular atrial fibrillation (NVAF) and treated with warfarin, rivaroxaban, and dabigatran vs apixaban. Methods Adult patients hospitalized...